Siemens, Philips, J&J Attuned To Stereotaxis Public Offering, Future Sales
This article was originally published in The Gray Sheet
Executive Summary
Stereotaxis will increase sales and marketing capacity for its Stereotaxis advanced cardiology instrument control system with part of the estimated $87.9 mil. the firm expects to raise through an IPO